The study consists to Identify viral variants involved in the transmission of hepatitis C and characterize the antigenic and functional properties of their envelope glycoproteins at very early stage of infection (before seroconversion).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
8
Specific intervention : blood sample (3x7 ml in total)
Chru de Tours
Tours, France, France
HCV serological markers
Immunoblot analysis from blood samples collected during the study
Time frame: up to 30 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.